TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 38nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 44nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 45.3nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 47nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 53nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 58nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 93nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 99.3nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 117nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 146nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 151nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 152nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 194nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 224nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 226nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 227nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 228nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 235nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 252nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 274nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 275nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 279nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 336nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 381nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 412nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 435nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 501nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 505nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 550nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 558nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 579nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 582nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 586nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 588nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 604nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 785nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 808nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 851nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 852nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 854nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 921nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 1.24E+3nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 1.24E+3nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 1.59E+3nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 1.62E+3nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 1.67E+3nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 1.76E+3nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 1.82E+3nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 1.82E+3nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR [1360-2549](Homo sapiens (Human))
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii
US Patent
Affinity DataIC50: 1.86E+3nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair